======= TDRD3 =======
== Gene Information ==
* **Official Symbol**: TDRD3
* **Official Name**: tudor domain containing 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=81550|81550]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9H7E2|Q9H7E2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TDRD3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TDRD3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/614392|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Scaffolding protein that specifically recognizes and binds dimethylarginine-containing proteins. In nucleus, acts as a coactivator: recognizes and binds asymmetric dimethylation on the core histone tails associated with transcriptional activation (H3R17me2a and H4R3me2a) and recruits proteins at these arginine- methylated loci. In cytoplasm, may play a role in the assembly and/or disassembly of mRNA stress granules and in the regulation of translation of target mRNAs by binding Arg/Gly-rich motifs (GAR) in dimethylarginine-containing proteins. {ECO:0000269|PubMed:15955813, ECO:0000269|PubMed:18632687, ECO:0000269|PubMed:21172665}.
|UBA|
|SMN|
|DUF1767|
|TUDOR|
|exon-exon junction complex|
|methylated histone binding|
|transcription coactivator activity|
|chromatin binding|
|chromatin organization|
|Golgi apparatus|
|chromosome organization|
|RNA binding|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp432|YM155 0.001μM R08 exp432]]|-1.93|
|[[:results:exp46|HMS-I1 1μM R01 exp46]]|-1.85|
|[[:results:exp275|Citral 75μM R06 exp275]]|-1.71|
|[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|1.74|
|[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.74|
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.82|
|[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|1.9|
|[[:results:exp495|IWR1 50μM R08 exp495]]|2.08|
|[[:results:exp502|Milciclib 2μM R08 exp502]]|2.34|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6417
* **Expression level (log2 read counts)**: 4.08
{{:chemogenomics:nalm6 dist.png?nolink |}}